Sinovac Biotech Co., Ltd
Clinical trials sponsored by Sinovac Biotech Co., Ltd, explained in plain language.
-
New mRNA vaccine aims to stop shingles in its tracks
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new mRNA vaccine designed to prevent shingles, a painful rash caused by the chickenpox virus. It involves 519 healthy adults aged 40 and older. The goal is to check the vaccine's safety and find the best dose to trigger a strong immune response.
Phase: PHASE1, PHASE2 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 15, 2026 19:06 UTC
-
Polio vaccine showdown: which shot works best for babies?
⭐️ VACCINE ⭐️ Recruiting nowThis study tests two different polio vaccines in 480 infants to see which one works better and is safer. The vaccines are given either as a shot under the skin or into the muscle. The goal is to find the best way to protect babies from polio.
Phase: PHASE4 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 15, 2026 19:05 UTC
-
New flu vaccine trial aims to protect moms and babies
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new flu vaccine in 150 healthy pregnant women aged 18-39, between 20 and 32 weeks of pregnancy. Participants receive either the new vaccine or an existing one, and researchers check immune response and safety for both mother and baby. The goal is to see if the …
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 09, 2026 12:10 UTC
-
One shot to protect: new polio vaccine study for teens and adults
⭐️ VACCINE ⭐️ Recruiting nowThis study compares a single dose of a polio vaccine (sIPV) given to 180 healthy people aged 7-50 years with the standard three-dose vaccine given to infants. The goal is to see if the single dose works as well and is just as safe. Researchers will measure antibody levels 30 days…
Phase: PHASE4 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 08, 2026 13:12 UTC